These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34073695)

  • 1. Application of Microbiome Management in Therapy for
    Chiu CW; Tsai PJ; Lee CC; Ko WC; Hung YP
    Pathogens; 2021 May; 10(6):. PubMed ID: 34073695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the gut microbiome in colonization resistance and recurrent
    Seekatz AM; Safdar N; Khanna S
    Therap Adv Gastroenterol; 2022; 15():17562848221134396. PubMed ID: 36425405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection.
    Haifer C; Paramsothy S; Borody TJ; Clancy A; Leong RW; Kaakoush NO
    mSystems; 2021 Feb; 6(1):. PubMed ID: 33531405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials.
    Madoff SE; Urquiaga M; Alonso CD; Kelly CP
    Anaerobe; 2020 Feb; 61():102098. PubMed ID: 31493500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent
    Stallhofer J; Steube A; Katzer K; Stallmach A
    Visc Med; 2024 Apr; 40(2):82-91. PubMed ID: 38584858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model.
    Tomkovich S; Lesniak NA; Li Y; Bishop L; Fitzgerald MJ; Schloss PD
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31748246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural product chlorotonil A preserves colonization resistance and prevents relapsing Clostridioides difficile infection.
    Bublitz A; Brauer M; Wagner S; Hofer W; Müsken M; Deschner F; Lesker TR; Neumann-Schaal M; Paul LS; Nübel U; Bartel J; Kany AM; Zühlke D; Bernecker S; Jansen R; Sievers S; Riedel K; Herrmann J; Müller R; Fuchs TM; Strowig T
    Cell Host Microbe; 2023 May; 31(5):734-750.e8. PubMed ID: 37098342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised clinical trial: a 12-strain bacterial mixture versus faecal microbiota transplantation versus vancomycin for recurrent Clostridioides difficile infections.
    Rode AA; Chehri M; Krogsgaard LR; Heno KK; Svendsen AT; Ribberholt I; Helms M; Engberg J; Schønning K; Tvede M; Andersen CØ; Jensen US; Petersen AM; Bytzer P
    Aliment Pharmacol Ther; 2021 May; 53(9):999-1009. PubMed ID: 33694229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert opinion on fecal microbiota transplantation for the treatment of
    Kumar V; Fischer M
    Expert Opin Biol Ther; 2020 Jan; 20(1):73-81. PubMed ID: 31690143
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical practice guidelines for Clostridioides (Clostridium) difficile infection and fecal microbiota transplant protocol - recommendations of the Polish Society od Epidemiology and Infectious Diseases.
    Piekarska A; Panasiuk A; Stępień PM
    Przegl Epidemiol; 2020; 74(1):69-87. PubMed ID: 32500988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst's FDA approval and implications.
    Jain N; Umar TP; Fahner AF; Gibietis V
    Gut Microbes; 2023; 15(1):2232137. PubMed ID: 37431860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT)
    Garza-González E; Mendoza-Olazarán S; Morfin-Otero R; Ramírez-Fontes A; Rodríguez-Zulueta P; Flores-Treviño S; Bocanegra-Ibarias P; Maldonado-Garza H; Camacho-Ortiz A
    Can J Gastroenterol Hepatol; 2019; 2019():4549298. PubMed ID: 31976311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
    Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M
    Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Faecal microbiota transplantation for Clostridioides difficile infection].
    Waldbaum C; López F; Antelo P; Sorda J
    Medicina (B Aires); 2020; 80(6):633-639. PubMed ID: 33254107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation for patients on antibiotic treatment with
    Kates AE; Gaulke I; De Wolfe T; Zimbric M; Haight K; Watson L; Suen G; Kim K; Safdar N
    Contemp Clin Trials Commun; 2020 Jun; 18():100576. PubMed ID: 32518854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation for treatment of patients with recurrent
    Voth E; Khanna S
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation for recurrent Clostridioides difficile infection.
    Haber SL; Raney CRK; Larson TL; Lau JP
    Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Spigaglia P
    Pathogens; 2024 Jul; 13(8):. PubMed ID: 39204246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.